Leqembi approved as first treatment to slow early Alzheimer’s progression
PharmaTimes
by John Pinching
11h ago
European Commission grants authorisation for Eisai and Biogen therapy ..read more
Visit website
Pepaxti shows effectiveness in heavily pretreated multiple myeloma patients
PharmaTimes
by John Pinching
11h ago
New real-world data reinforce treatment benefit ..read more
Visit website
New data reinforce daratumumab as standard of care for multiple myeloma
PharmaTimes
by John Pinching
1d ago
Long-term survival projections suggest improved outcomes for patients ..read more
Visit website
Global data highlights effectiveness of romosozumab
PharmaTimes
by John Pinching
1d ago
Studies show improved bone mineral density and healthcare cost reductions ..read more
Visit website
UK clinical trials regulations signed into law
PharmaTimes
by John Pinching
2d ago
Major update aims to accelerate research and strengthen patient safety ..read more
Visit website
New test prototype for monitoring MGUS patients funded
PharmaTimes
by John Pinching
2d ago
Birmingham researchers to make MGUS monitoring more efficient ..read more
Visit website
First treatment for common bladder cancer recommended by NICE
PharmaTimes
by Ella Day
6d ago
Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration ..read more
Visit website
Lab-grown lung cancer cells show potential to revolutionise treatment
PharmaTimes
by Ella Day
6d ago
The model could lead to more targeted treatments for the disease ..read more
Visit website
NHS launches spring COVID-19 booster campaign
PharmaTimes
by Ella Day
1w ago
An estimated 7.5 million people will be invited to receive the booster ..read more
Visit website
SkyCell and Microsoft partner to improve pharma supply chains
PharmaTimes
by Ella Day
1w ago
AI-powered SkyMind is designed to improve efficiency, compliance and decision-making ..read more
Visit website

Follow PharmaTimes on FeedSpot

Continue with Google
Continue with Apple
OR